These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Verbal fluency deficits in Parkinson's disease: a meta-analysis. Henry JD; Crawford JR J Int Neuropsychol Soc; 2004 Jul; 10(4):608-22. PubMed ID: 15327739 [TBL] [Abstract][Full Text] [Related]
3. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)]. Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451 [TBL] [Abstract][Full Text] [Related]
4. A meta-analytic review of verbal fluency deficits in Huntington's disease. Henry JD; Crawford JR; Phillips LH Neuropsychology; 2005 Mar; 19(2):243-52. PubMed ID: 15769208 [TBL] [Abstract][Full Text] [Related]
5. Verbal fluency performance in dementia of the Alzheimer's type: a meta-analysis. Henry JD; Crawford JR; Phillips LH Neuropsychologia; 2004; 42(9):1212-22. PubMed ID: 15178173 [TBL] [Abstract][Full Text] [Related]
6. Verbal fluency in schizophrenia: does cognitive performance reflect the same underlying mechanisms in patients and healthy controls? Ojeda N; Sánchez P; Peña J; Elizagárate E; Yoller AB; Larumbe J; Gutiérrez M; Casais L; Ezcurra J J Nerv Ment Dis; 2010 Apr; 198(4):286-91. PubMed ID: 20386258 [TBL] [Abstract][Full Text] [Related]
7. Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study. Patti F; Amato MP; Trojano M; Bastianello S; Tola MR; Goretti B; Caniatti L; Di Monte E; Ferrazza P; Brescia Morra V; Lo Fermo S; Picconi O; Luccichenti G; Mult Scler; 2009 Jul; 15(7):779-88. PubMed ID: 19542262 [TBL] [Abstract][Full Text] [Related]
8. Rapid serial processing in patients with multiple sclerosis: the role of peripheral deficits. Bodling AM; Denney DR; Lynch SG J Int Neuropsychol Soc; 2008 Jul; 14(4):646-50. PubMed ID: 18577294 [TBL] [Abstract][Full Text] [Related]
9. Cognitive deficits in multiple sclerosis patients with cerebellar symptoms. Valentino P; Cerasa A; Chiriaco C; Nisticò R; Pirritano D; Gioia M; Lanza P; Canino M; Del Giudice F; Gallo O; Condino F; Torchia G; Quattrone A Mult Scler; 2009 Jul; 15(7):854-9. PubMed ID: 19542264 [TBL] [Abstract][Full Text] [Related]
10. Language functions in patients with multiple sclerosis. Friend KB; Rabin BM; Groninger L; Deluty RH; Bever C; Grattan L Clin Neuropsychol; 1999 Feb; 13(1):78-94. PubMed ID: 10937650 [TBL] [Abstract][Full Text] [Related]
12. A meta-analytic review of verbal fluency performance following focal cortical lesions. Henry JD; Crawford JR Neuropsychology; 2004 Apr; 18(2):284-95. PubMed ID: 15099151 [TBL] [Abstract][Full Text] [Related]
13. A meta-analytic review of verbal fluency performance in patients with traumatic brain injury. Henry JD; Crawford JR Neuropsychology; 2004 Oct; 18(4):621-8. PubMed ID: 15506829 [TBL] [Abstract][Full Text] [Related]
14. Reaction time: An alternative method for assessing the effects of multiple sclerosis on information processing speed. Reicker LI; Tombaugh TN; Walker L; Freedman MS Arch Clin Neuropsychol; 2007 Jun; 22(5):655-64. PubMed ID: 17532182 [TBL] [Abstract][Full Text] [Related]
15. Sensitivity of conventional memory tests in multiple sclerosis: comparing the Rao Brief Repeatable Neuropsychological Battery and the Minimal Assessment of Cognitive Function in MS. Strober L; Englert J; Munschauer F; Weinstock-Guttman B; Rao S; Benedict RH Mult Scler; 2009 Sep; 15(9):1077-84. PubMed ID: 19556311 [TBL] [Abstract][Full Text] [Related]
16. Cognitive impairment differs between primary progressive and relapsing-remitting MS. Ruet A; Deloire M; Charré-Morin J; Hamel D; Brochet B Neurology; 2013 Apr; 80(16):1501-8. PubMed ID: 23516324 [TBL] [Abstract][Full Text] [Related]
17. Covariates of production and perseveration on tests of phonemic, semantic and alternating fluency in normal aging. Henry JD; Phillips LH Neuropsychol Dev Cogn B Aging Neuropsychol Cogn; 2006; 13(3-4):529-51. PubMed ID: 16887788 [TBL] [Abstract][Full Text] [Related]
18. A comparison of memory performance in relapsing-remitting, primary progressive and secondary progressive, multiple sclerosis. Gaudino EA; Chiaravalloti ND; DeLuca J; Diamond BJ Neuropsychiatry Neuropsychol Behav Neurol; 2001 Jan; 14(1):32-44. PubMed ID: 11234907 [TBL] [Abstract][Full Text] [Related]
19. Lesion probability mapping to explain clinical deficits and cognitive performance in multiple sclerosis. Kincses ZT; Ropele S; Jenkinson M; Khalil M; Petrovic K; Loitfelder M; Langkammer C; Aspeck E; Wallner-Blazek M; Fuchs S; Jehna M; Schmidt R; Vécsei L; Fazekas F; Enzinger C Mult Scler; 2011 Jun; 17(6):681-9. PubMed ID: 21177325 [TBL] [Abstract][Full Text] [Related]
20. Association of neocortical volume changes with cognitive deterioration in relapsing-remitting multiple sclerosis. Amato MP; Portaccio E; Goretti B; Zipoli V; Battaglini M; Bartolozzi ML; Stromillo ML; Guidi L; Siracusa G; Sorbi S; Federico A; De Stefano N Arch Neurol; 2007 Aug; 64(8):1157-61. PubMed ID: 17698706 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]